High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan

American Journal of Kidney Diseases

Volumn 43, Issue 6, 2004, Pages 1091-1097

  Wu, Ming Ju ^c   Lian, Jong Da ^c   Yang, Chi Rei ^c   Cheng, Chi Hung ^c   Chen, Cheng Hsu ^c   Lee, Wen Chin ^c   Shu, Kuo Hsiung ^a   Tang, Ming Jer ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NONE

Author keywords

Kidney transplantation; Malignancy; Transitional cell carcinoma (TCC)

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; BASILIXIMAB; CISPLATIN; CYCLOSPORIN; DACLIZUMAB; EPIRUBICIN; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHINESE HERB; CLINICAL FEATURE; FEMALE; FLUID INTAKE; FOLLOW UP; HEMATURIA; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 2542439848     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.03.016     Document Type: Article

References (28)

1. Birkeland SA, Lokkegaard H, Storm HH: Cancer risk in patients on dialysis and after renal transplantation. Lancet 35:1886-1887, 2000
2. Penn I: De novo cancers in organ allograft recipients. Cur Opin Organ Transplant 3:188-196, 1998
3. Penn I: Cancers in renal transplant recipients. Adv Renal Replace Ther 7:147-156, 2000
4. Gaya SBM, Rees AJ, Lechler RI, Williams G, Mason PD: Malignant disease in patients with long-term renal transplants. Transplantation 59:1705-1709, 1995
5. Gifford RR, Wofford JE, Edwards WG Jr: Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin Transplant 12:65-69, 1998
6. Swindle P, Falk M, Rigby R, Petrie J, Hawley C, Nicol D: Transitional cell carcinoma in renal transplant recipients: The influence of compound analgesics. Br J Urol 81:229-233, 1998
7. Kliem V, Thon W, Krautzig S: High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation. Transplant Int 9:231-235, 1996
8. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de SC: Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33:1011-1017, 1999
9. Nortier JL, Martinez MCM, Schmeiser HH, et al: Urothelial carcinoma associated with the use of a Chinese herb (aristolochia fangchi). N Engl J Med 342:1686-1692, 2000
10. Chiou HY, Chiou ST, Hsu YH, et al: Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411-418, 2001
11. Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF: The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 71:274-278, 1993
12. Department of Health, Excutive Yuan, Republic of China: Cancer Registry Annual Report in Taiwan Area, 1999
13. Bailar JC, Ederer F: Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 20:639-643, 1964
14. Wang HB, Hsieh HH, Chen YT, Chiang CY, Cheng YT: The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients. Clin Transplant 16:410-413, 2002
15. Ou JH, Pan CC, Lin JSN, et al: Transitional cell carcinoma in dialysis patients. Euro Urol 37:90-94, 2000
16. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML: Urologic cancers in uremic patients. Am J Kidney Dis 25:694-700, 1995
17. Kalble T: Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer. Urologe A 40:447-450, 2001
18. Swanson MA, Schwartz RS: Immunosuppresive therapy: The relation between clinical response and immunologic competence. N Engl J Med 227:163-167, 1967
19. Herman M, Weinstein T, Korzets A: Effect of cyclosporine A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 137:14-20, 2001
20. Gonwa TA, Corbett WT, Schey HM, Buckalew VM: Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93:249-252, 1980
21. McCredie M, Ford JM, Taylor JS, Stewart JH: Analgesics and cancer of the renal pelvis in New South Wales. Cancer 49:2617-2625, 1982
22. Hauser AC, Derfler K, Stockenhuber F, Balcke P: Post-transplantation malignant disease in patients with analgesic nephropathy. Lancet 1:335, 1990
23. Schwarz A, Offermann G, Keller F: Analgesic nephropathy and renal transplantation. 7:427-4321992
24. Vanherweghem LJ: Misuse of herbal remedies: The case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 4:9-13, 1998
25. Nortier JL, Vanherweghem JL: Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 181-182:577-580, 2002
26. Hsieh YF, Ling GC, Lu YB: Incidence of tumor of renal pelvis in Taiwan. J Formos Med Assoc 78:749-754, 1979
27. Tzeng CC, Liu HS, Li C: Characterization of two urothelium cancer cell lines derived from a black foot disease endemic area in Taiwan. Anticancer Res 16:1797-1805, 1996
28. Environmental Protection Agency. National Primary Drinking Water Regulations: Arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Fed Reg 66:6976-7066, 2001